{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T10:40:31Z","timestamp":1785408031778,"version":"3.56.0"},"reference-count":58,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T00:00:00Z","timestamp":1768176000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Nutr."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Epilepsy is a prevalent chronic neurological disorder. A substantial proportion of patients develop drug-resistant epilepsy. Existing antiepileptic drugs are associated with adverse effects and demonstrate limited efficacy in refractory cases. Oxidative stress plays a critical role in the pathogenesis of epilepsy. Antioxidants such as vitamin D, vitamin E, and melatonin, as well as dietary therapies like the ketogenic diet, have garnered attention as potential adjunctive treatments. However, existing studies exhibit significant controversy and heterogeneity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To evaluate the efficacy and safety of antioxidants and dietary therapies in the treatment of epilepsy, and to provide evidence-based support for clinical decision-making.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Systematic searches were conducted in PubMed, Web of Science, Embase, and the Cochrane Library. Eighteen eligible meta-analyses were selected for umbrella review based on predefined criteria. Pooled relative risks (RR) with 95% confidence intervals (CI) were calculated using random-effects or fixed-effects models. Heterogeneity was assessed using the I\n                      <jats:sup>2<\/jats:sup>\n                      statistic, and evidence quality was evaluated with the AMSTAR 2 tool.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Dietary therapies\u2014particularly the Low Glycemic Index Treatment (LGIT)\u2014significantly increased the likelihood of achieving \u226550% (RR: 1.95; 95% CI: 1.58\u20132.33) and \u226590% (RR: 3.33; 95% CI: 1.51\u20135.14) seizure reduction. However, dietary therapies were ineffective in achieving seizure freedom (RR: 0.68; 95% CI: 0.00\u20131.36). In subgroup analyses of \u226550% seizure reduction, antioxidants did not demonstrate significant efficacy. Both antioxidants and dietary therapies significantly increased the overall incidence of adverse events (RR: 1.56; 95% CI: 1.19\u20131.92). Specifically, the ketogenic diet elevated the risks of dyslipidemia (RR: 3.56; 95% CI: 2.00\u20135.11), weight loss (RR: 4.80; 95% CI: 3.43\u20136.17), constipation (RR: 3.02; 95% CI: 1.55\u20134.48), and kidney stones (RR: 5.24; 95% CI: 3.73\u20136.74). Melatonin was ineffective in reducing seizure frequency (RR: 0.30; 95% CI: 0.00\u20130.63). Considerable heterogeneity was observed across studies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Dietary therapies\u2014notably LGIT\u2014demonstrate clear efficacy in reducing seizure frequency but do not facilitate seizure freedom. Current evidence does not support the use of antioxidants as effective adjunctive therapy for epilepsy. These interventions, particularly the ketogenic diet, are associated with increased risks of adverse effects, necessitating careful benefit\u2013risk assessment in clinical application.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Systematic review registration<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link>https:\/\/www.crd.york.ac.uk\/PROSPERO\/view\/CRD420251166437<\/jats:ext-link>\n                      , identifier: CRD420251166437.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fnut.2025.1723370","type":"journal-article","created":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T05:40:07Z","timestamp":1768196407000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Efficacy and safety of antioxidants and dietary therapies for epilepsy: an umbrella meta-analysis"],"prefix":"10.3389","volume":"12","author":[{"given":"Yingqi","family":"Feng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanshan","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengyao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujia","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyu","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rutong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shen","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,1,12]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"108026","DOI":"10.1016\/j.pharmthera.2021.108026","article-title":"New advances in pharmacoresistant epilepsy towards precise management-from prognosis to treatments","volume":"233","author":"Xu","year":"2022","journal-title":"Pharmacol Ther"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/978-1-4614-0653-2_8","article-title":"Epilepsy and epileptic syndrome","volume":"724","author":"Ono","year":"2012","journal-title":"Adv Exp Med Biol"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1124\/pr.120.019539","article-title":"Drug resistance in epilepsy: clinical impact, potential mechanisms, and new innovative treatment options","volume":"72","author":"L\u00f6scher","year":"2020","journal-title":"Pharmacol Rev"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines9050470","article-title":"Pharmacological and therapeutic approaches in the treatment of epilepsy","volume":"9","author":"Ghosh","year":"2021","journal-title":"Biomedicine"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s42494-021-00055-z","article-title":"The pharmacological treatment of epilepsy: recent advances and future perspectives","volume":"3","author":"Perucca","year":"2021","journal-title":"Acta Epileptol"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1007\/s43440-020-00143-w","article-title":"Role of oxidative stress in epileptogenesis and potential implications for therapy","volume":"72","author":"Borowicz-Reutt","year":"2020","journal-title":"Pharmacological reports: PR"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.neuint.2011.03.025","article-title":"Role of oxidative stress in epileptic seizures","volume":"59","author":"Shin","year":"2011","journal-title":"Neurochem Int"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.tox.2010.04.008","article-title":"Melatonin: action as antioxidant and potential applications in human disease and aging","volume":"278","author":"Bonnefont-Rousselot","year":"2010","journal-title":"Toxicology"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1038\/s41398-021-01464-x","article-title":"Melatonin's neuroprotective role in mitochondria and its potential as a biomarker in aging, cognition and psychiatric disorders","volume":"11","author":"Melhuish Beaupre","year":"2021","journal-title":"Transl Psychiatry"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"947567","DOI":"10.3389\/fnut.2022.947567","article-title":"Ketogenic diets and ketone suplementation: a strategy for therapeutic intervention","volume":"9","author":"Saris","year":"2022","journal-title":"Front Nutr"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"2329048x18779497","DOI":"10.1177\/2329048x18779497","article-title":"Ketogenic diet in refractory childhood epilepsy: starting with a liquid formulation in an outpatient setting","volume":"5","author":"Weijenberg","year":"2018","journal-title":"Child Neurol Open"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"Cd001903","DOI":"10.1002\/14651858.CD001903.pub3","article-title":"Ketogenic diet and other dietary treatments for epilepsy","volume":"2","author":"Martin","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"1322509","DOI":"10.3389\/fnut.2024.1322509","article-title":"Ketogenic diet and behavior: insights from experimental studies","volume":"11","author":"Grabowska","year":"2024","journal-title":"Front Nutr"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"527","DOI":"10.2174\/1570159x12666140923205715","article-title":"Antioxidants as a preventive treatment for epileptic process: a review of the current status","volume":"12","author":"Martinc","year":"2014","journal-title":"Curr Neuropharmacol"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"e26813","DOI":"10.1016\/j.heliyon.2024.e26813","article-title":"Diet-derived circulating antioxidants and risk of epilepsy: a study combining metabolomics and mendelian randomization","volume":"10","author":"Liang","year":"2024","journal-title":"Heliyon"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"e9639","DOI":"10.7759\/cureus.9639","article-title":"Advantages and disadvantages of the ketogenic diet: a review article","volume":"12","author":"Batch","year":"2020","journal-title":"Cureus"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"b2535","DOI":"10.1136\/bmj.b2535","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"339","author":"Moher","year":"2009","journal-title":"BMJ"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ (Clinical research ed)"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"j4008","DOI":"10.1136\/bmj.j4008","article-title":"AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both","volume":"358","author":"Shea","year":"2017","journal-title":"BMJ (Clinical research ed.)"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"1628032","DOI":"10.3389\/fneur.2025.1628032","article-title":"Efficacy and safety of vitamin E as adjunctive therapy for epilepsy: a systematic review and meta-analysis of randomized control trials","volume":"16","author":"Li","year":"2025","journal-title":"Front Neurol"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"2240","DOI":"10.1186\/s12889-024-19794-y","article-title":"Association between composite dietary antioxidant index and epilepsy in American population: a cross-sectional study from NHANES","volume":"24","author":"Zhang","year":"2024","journal-title":"BMC Public Health"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.3390\/nu16091258","article-title":"Ketogenic diet in the treatment of epilepsy","volume":"16","author":"Borowicz-Reutt","year":"2024","journal-title":"Nutrients"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1007\/s00415-017-8394-2","article-title":"Recent advances in epilepsy","volume":"264","author":"Manford","year":"2017","journal-title":"J Neurol"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1212\/01.Con.0000431380.21685.75","article-title":"Antiepileptic drug treatment: new drugs and new strategies","volume":"19","author":"French","year":"2013","journal-title":"Continuum"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.yebeh.2014.05.031","article-title":"The consequences of refractory epilepsy and its treatment","volume":"37","author":"Laxer","year":"2014","journal-title":"Epilepsy & behavior: E&B"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"795259","DOI":"10.1155\/2012\/795259","article-title":"Oxidative stress and epilepsy: literature review","volume":"2012","author":"Aguiar","year":"2012","journal-title":"Oxidative Med Cell Longev"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/s44371-025-00275-z","article-title":"Reactive oxygen species (ROS): sources, generation, disease pathophysiology, and antioxidants","volume":"2","author":"Ansari","year":"2025","journal-title":"Discover Chem"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.3390\/nu15194161","article-title":"Ketogenic diet and multiple health outcomes: An umbrella review of Meta-analysis","volume":"15","author":"Chen","year":"2023","journal-title":"Nutrients"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1055\/s-0035-1558435","article-title":"The effects of ketogenic diet on seizures, cognitive functions, and other neurological disorders in classical phenotype of glucose transporter 1 deficiency syndrome","volume":"46","author":"Gumus","year":"2015","journal-title":"Neuropediatrics"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21197152","article-title":"Neuroprotective effect of antioxidants in the brain","volume":"21","author":"Lee","year":"2020","journal-title":"Int J Mol Sci"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.freeradbiomed.2024.11.019","article-title":"Safeguarding the brain from oxidative damage","volume":"226","author":"Lee","year":"2025","journal-title":"Free Radic Biol Med"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"2499","DOI":"10.1007\/s00204-023-03562-9","article-title":"Reactive oxygen species, toxicity, oxidative stress, and antioxidants: chronic diseases and aging","volume":"97","author":"Jomova","year":"2023","journal-title":"Arch Toxicol"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/s0163-7827(99)00008-9","article-title":"Vitamin E and its function in membranes","volume":"38","author":"Wang","year":"1999","journal-title":"Prog Lipid Res"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s42494-024-00173-4","article-title":"The associations between oxidative stress and epilepsy: a bidirectional two-sample Mendelian randomization study","volume":"6","author":"Zhang","year":"2024","journal-title":"Acta Epileptol"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.3390\/antiox7050063","article-title":"Anti-oxidant and anti-inflammatory activity of ketogenic diet: new perspectives for neuroprotection in Alzheimer's disease","volume":"7","author":"Pinto","year":"2018","journal-title":"Antioxidants (Basel, Switzerland)"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"106050","DOI":"10.1016\/j.biocel.2021.106050","article-title":"The ketogenic diet as a therapeutic intervention strategy in mitochondrial disease","volume":"138","author":"Qu","year":"2021","journal-title":"Int J Biochem Cell Biol"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"354","DOI":"10.22038\/ajp.2023.21774","article-title":"Review of the antioxidant potential of flavonoids as a subgroup of polyphenols and partial substitute for synthetic antioxidants","volume":"13","author":"Hassanpour","year":"2023","journal-title":"Avicenna journal of phytomedicine"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"e71018","DOI":"10.1002\/brb3.71018","article-title":"Dietary antioxidant quality score and epilepsy odds in the US adults: a cross-sectional NHANES study","volume":"15","author":"Abbasi","year":"2025","journal-title":"Brain and behavior"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.20960\/nh.05668","article-title":"Adherence to an antioxidant diet is associated with reduced risk of epilepsy among American adults - NHANES 2013-2018. La adherencia a una dieta antioxidante se asocia a un riesgo reducido de epilepsia entre los adultos estadounidenses: NHANES 2013-2018","volume":"45","author":"Wang","year":"2025","journal-title":"Nutr Hosp"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/s41421-023-00636-x","article-title":"Ketogenic diet-produced \u03b2-hydroxybutyric acid accumulates brain GABA and increases GABA\/glutamate ratio to inhibit epilepsy","volume":"10","author":"Qiao","year":"2024","journal-title":"Cell discovery"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1002\/acn3.70017","article-title":"High-fat and low-carbohydrate dietary environments are linked to reduced idiopathic epilepsy incidence and prevalence","volume":"12","author":"Ni","year":"2025","journal-title":"Annals of clinical and translational neurology"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.seizure.2023.09.010","article-title":"Modified Atkins diet for drug-resistant epilepsy: a systematic review and meta-analysis of randomized controlled trials","volume":"112","author":"Mutarelli","year":"2023","journal-title":"Seizure"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"193","DOI":"10.2310\/7010.2006.00044","article-title":"Efficacy of the ketogenic diet as a treatment option for epilepsy: meta-analysis","volume":"21","author":"Henderson","year":"2006","journal-title":"J Child Neurol"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1080\/14737175.2022.2030220","article-title":"Ketogenic diet in pediatric seizures: a randomized controlled trial review and meta-analysis","volume":"22","author":"Pizzo","year":"2022","journal-title":"Expert Rev Neurother"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1002\/epi4.12098","article-title":"Ketogenic diet for treatment of intractable epilepsy in adults: a meta-analysis of observational studies","volume":"3","author":"Liu","year":"2018","journal-title":"Epilepsia open"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"2557","DOI":"10.1007\/s00381-021-05174-z","article-title":"Efficacy and safety of corpus callosotomy and ketogenic diet in children with Lennox Gastaut syndrome: a systematic review and meta-analysis","volume":"37","author":"Sharawat","year":"2021","journal-title":"Child's nervous system: ChNS: official journal of the International Society for Pediatric Neurosurgery"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1186\/s13023-022-02492-6","article-title":"Efficacy of ketogenic diet in CDKL5-related epilepsy: a single arm meta-analysis","volume":"17","author":"Zhang","year":"2022","journal-title":"Orphanet J Rare Dis"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1007\/s00381-020-04578-7","article-title":"Ketogenic diet for the treatment of pediatric epilepsy: review and meta-analysis","volume":"36","author":"Sourbron","year":"2020","journal-title":"Child's nervous system: ChNS: official journal of the International Society for Pediatric Neurosurgery"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"110434","DOI":"10.1016\/j.yebeh.2025.110434","article-title":"Efficacy and compliance of carbohydrate-restricted diets for treating drug-resistant epilepsy: a network meta-analysis of randomized controlled trials","volume":"168","author":"Zhu","year":"2025","journal-title":"Epilepsy & behavior: E&B"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"Cd004304","DOI":"10.1002\/14651858.CD004304.pub2","article-title":"Vitamins for epilepsy","author":"Ranganathan","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.14581\/jer.24001","article-title":"Modified Atkins diet in adolescents and adults with drug resistant epilepsy: a systematic review and Meta-analysis","volume":"14","author":"Manral","year":"2024","journal-title":"Journal of epilepsy research"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"Cd001903","DOI":"10.1002\/14651858.CD001903.pub5","article-title":"Ketogenic diets for drug-resistant epilepsy","volume":"6","author":"Martin-McGill","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.seizure.2025.01.018","article-title":"Illuminating the safety, tolerability, and efficacy of different ketogenic diets for individuals with epilepsy: a scoping Meta-review","volume":"125","author":"Abbasi","year":"2025","journal-title":"Seizure"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1007\/s11845-024-03622-8","article-title":"The impact of ketogenic diet on drug-resistant epilepsy in children: a comprehensive review and meta-analysis","volume":"193","author":"Mustafa","year":"2024","journal-title":"Ir J Med Sci"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1001\/jamapediatrics.2022.5648","article-title":"Efficacy and safety of dietary therapies for childhood drug-resistant epilepsy: a systematic review and network Meta-analysis","volume":"177","author":"Devi","year":"2023","journal-title":"JAMA Pediatr"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"244","DOI":"10.3389\/fneur.2019.00244","article-title":"Three and six months of ketogenic diet for intractable childhood epilepsy: a systematic review and Meta-analysis","volume":"10","author":"Liu","year":"2019","journal-title":"Front Neurol"},{"key":"ref57","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.seizure.2025.03.003","article-title":"Can Omega-3 fatty acid supplementation support the clinical management of drug-resistant epilepsy? A meta-analysis of randomized controlled trials","volume":"127","author":"Meng","year":"2025","journal-title":"Seizure"},{"key":"ref58","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.seizure.2024.02.016","article-title":"Melatonin as an add-on treatment for epilepsy: a systematic review and meta-analysis","volume":"117","author":"Liu","year":"2024","journal-title":"Seizure"}],"container-title":["Frontiers in Nutrition"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnut.2025.1723370\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T05:40:09Z","timestamp":1768196409000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnut.2025.1723370\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,12]]},"references-count":58,"alternative-id":["10.3389\/fnut.2025.1723370"],"URL":"https:\/\/doi.org\/10.3389\/fnut.2025.1723370","relation":{},"ISSN":["2296-861X"],"issn-type":[{"value":"2296-861X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,12]]},"article-number":"1723370"}}